Stay updated on Pfizer Press Releases
Sign up to get notified when there's something new on the Pfizer Press Releases page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FA6vSeX6UN8An0CX4v_FoW-Cy_hM.uncropped.jpg&w=3840&q=75)
Latest updates to the Pfizer Press Releases page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check81 days agoChange DetectedThe webpage now shows that Pfizer has announced a new Chief Strategy and Innovation Officer on 05.06.2024, indicating a significant leadership change within the company.SummaryDifference100%
- Check86 days agoChange DetectedThe value on the webpage has changed to 05.01.2024, indicating that Pfizer has reported its First-Quarter 2024 Results. This change likely represents a significant announcement or press release regarding Pfizer's financial performance for the first quarter of 2024.SummaryDifference43%
- Check87 days agoChange DetectedThe value on the webpage has changed to '04.29.2024 Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting.' This change represents a recent update on Pfizer's progress in accelerating breakthrough cancer medicines at the ASCO 2024 Annual Meeting.SummaryDifference82%
- Check90 days agoChange DetectedThe value on the webpage has changed to '04.26.2024 U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B.' This change represents the approval of Pfizer's gene therapy by the U.S. FDA for the treatment of adults with Hemophilia B.SummaryDifference100%
- Check91 days agoChange DetectedThe value on the webpage has changed to 04.25.2024, indicating that Pfizer has announced the preliminary results of their 2024 Shareholder Meeting. This change likely represents a significant update or development related to Pfizer's corporate activities.SummaryDifference53%
- Check94 days agoChange DetectedThe value on the webpage has changed to 04.22.2024, indicating that the European Commission has approved PfizerÔÇÖs EMBLAVEO┬« for patients with multidrug-resistant infections and limited treatment options.SummaryDifference100%
Stay in the know with updates to Pfizer Press Releases
Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.